New York, NY, United States of America

Mihaela Skobe

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mihaela Skobe: Innovator in Cancer Treatment

Introduction

Mihaela Skobe is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapies. Her work focuses on enhancing the effectiveness of cancer treatments using advanced technologies.

Latest Patents

Mihaela Skobe holds a patent for "Photoimmunotherapies for cancer using combination therapies." This invention relates to photosensitizer immunoconjugate compositions and combination therapies for use in cancer-related photodynamic treatments and diagnostic methods. The patent describes photosensitizer immunoconjugates comprising a photosensitizer conjugated to a tumor-specific and/or tumoricidal antibody. The processes for the preparation of these immunoconjugates are also detailed. The use of photosensitizer immunoconjugates (PICs) offers improved delivery specificity for diagnostic and therapeutic applications. Additionally, the patent outlines combination therapies designed to co-localize activated photosensitizer compounds and tumoricidal antibodies in tumor tissues.

Career Highlights

Mihaela Skobe is associated with The General Hospital Corporation, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment methodologies. She has demonstrated a commitment to advancing medical science through her innovative approaches.

Collaborations

Some of her notable coworkers include Tayyaba Hasan and Mark D Savellano. Their collaborative efforts contribute to the ongoing research and development in the field of cancer therapies.

Conclusion

Mihaela Skobe is a trailblazer in the field of cancer treatment, with her innovative patent and dedication to research. Her contributions are paving the way for more effective therapies that could significantly impact patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…